X-102127492-C-T

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_080390.4(TCEAL2):​c.662C>T​(p.Thr221Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00016 in 1,177,270 control chromosomes in the GnomAD database, including 1 homozygotes. There are 51 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00033 ( 1 hom., 11 hem., cov: 23)
Exomes 𝑓: 0.00014 ( 0 hom. 40 hem. )

Consequence

TCEAL2
NM_080390.4 missense

Scores

1
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.262
Variant links:
Genes affected
TCEAL2 (HGNC:29818): (transcription elongation factor A like 2) This gene encodes a member of the transcription elongation factor A (SII)-like (TCEAL) gene family. Members of this family contain TFA domains and may function as nuclear phosphoproteins that modulate transcription in a promoter context-dependent manner. Multiple family members are located on the X chromosome. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.00908795).
BS2
High Hemizygotes in GnomAd4 at 11 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TCEAL2NM_080390.4 linkc.662C>T p.Thr221Ile missense_variant Exon 3 of 3 ENST00000372780.6 NP_525129.1 Q9H3H9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TCEAL2ENST00000372780.6 linkc.662C>T p.Thr221Ile missense_variant Exon 3 of 3 1 NM_080390.4 ENSP00000361866.1 Q9H3H9
TCEAL2ENST00000329035.2 linkc.662C>T p.Thr221Ile missense_variant Exon 3 of 3 5 ENSP00000332359.2 Q9H3H9
TCEAL2ENST00000651085.1 linkn.153+1047C>T intron_variant Intron 2 of 3

Frequencies

GnomAD3 genomes
AF:
0.000332
AC:
37
AN:
111517
Hom.:
1
Cov.:
23
AF XY:
0.000325
AC XY:
11
AN XY:
33795
show subpopulations
Gnomad AFR
AF:
0.000849
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000283
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000166
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000113
Gnomad OTH
AF:
0.000668
GnomAD3 exomes
AF:
0.000182
AC:
27
AN:
148070
Hom.:
0
AF XY:
0.000146
AC XY:
7
AN XY:
48102
show subpopulations
Gnomad AFR exome
AF:
0.000837
Gnomad AMR exome
AF:
0.000622
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000431
Gnomad OTH exome
AF:
0.000286
GnomAD4 exome
AF:
0.000142
AC:
151
AN:
1065753
Hom.:
0
Cov.:
31
AF XY:
0.000116
AC XY:
40
AN XY:
345273
show subpopulations
Gnomad4 AFR exome
AF:
0.000847
Gnomad4 AMR exome
AF:
0.000626
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000332
Gnomad4 SAS exome
AF:
0.0000841
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000116
Gnomad4 OTH exome
AF:
0.000224
GnomAD4 genome
AF:
0.000332
AC:
37
AN:
111517
Hom.:
1
Cov.:
23
AF XY:
0.000325
AC XY:
11
AN XY:
33795
show subpopulations
Gnomad4 AFR
AF:
0.000849
Gnomad4 AMR
AF:
0.000283
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.000166
Gnomad4 NFE
AF:
0.000113
Gnomad4 OTH
AF:
0.000668
Bravo
AF:
0.000518
ESP6500AA
AF:
0.000271
AC:
1
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000207
AC:
25

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Oct 06, 2023
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.662C>T (p.T221I) alteration is located in exon 3 (coding exon 1) of the TCEAL2 gene. This alteration results from a C to T substitution at nucleotide position 662, causing the threonine (T) at amino acid position 221 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.090
BayesDel_addAF
Benign
-0.88
T
BayesDel_noAF
Benign
-1.1
CADD
Benign
5.2
DANN
Benign
0.95
DEOGEN2
Benign
0.0028
T;T
FATHMM_MKL
Benign
0.00019
N
LIST_S2
Benign
0.15
T;.
M_CAP
Benign
0.0056
T
MetaRNN
Benign
0.0091
T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
-0.69
N;N
PrimateAI
Uncertain
0.66
T
PROVEAN
Benign
1.4
N;N
REVEL
Benign
0.037
Sift
Benign
0.80
T;T
Sift4G
Benign
0.52
T;T
Polyphen
0.0050
B;B
Vest4
0.072
MVP
0.043
MPC
0.10
ClinPred
0.0022
T
GERP RS
1.0
Varity_R
0.034
gMVP
0.020

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs374962229; hg19: chrX-101382464; API